schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group: patients will be treated with melatonin tablet (3 mg) which is prepared in RAZAK drug company. The intervention group will receive two melatonin tablets 3 mg (6 mg
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients who have admitted in psychiatry ward of Golestan hospital Age 18-65 years Schizophrenic patient according to DSM-5 Satisfaction of patients' guardianship Schizophrenic patients who have treated with risperidone
Exclusion criteria
Exclusion criteria: Treatment with any psych medications except for risperidone Comorbidity of other psychopathologies Abuse of any substance, drug, or alcohol Drug reaction to melatonin or placebo Past history of treatment with clozapine or melatonin Pregnancy, mental retardation or any other neurologic and neurocognitive disorders, sleep apnea Proven depression according to Calgary scale Treatment with ECT in the current episode
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of positive and negative symptoms according to PANSS scale. Timepoint: At the start of intervention, 3 weeks and 6 weeks later. Method of measurement: positive and negative syndrome scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSanam Anoosheh
Ahvaz University of Medical Sciences
Outcome results
None listed